Home|Journals|Articles by Year|Audio Abstracts RSS - TOC
 

Original Research



Investigation of the relationship between cannabis use, opioid use and cognitive errors

Mehmet Hamdi Orum.




Abstract

Cognitive errors associated with cannabis and opioid have been investigated and compared, but the relationship between cognitive errors questioning personal achievements (PA) and interpersonal relationships (IP) with these two types of substance has not been adequately investigated. We aimed to compare comorbid psychiatric symptoms, cognitive errors and substance use characteristics of patients diagnosed with cannabis use disorder (CUD) and opioid use disorder (OUD). In this cross-sectional study, Symptom Checklist-90-Revised (SCL-90-R) was used and a sociodemographic data was obtained. The cognitive distortions scale (CDS) was used to evaluate cognitive errors. The patient group consisted of 60 (30 CUD and 30 OUD) and the control group consisted of 30 males. Patient and control groups were similar in terms of mean age and educational status (p>0.05). The mean duration of substance use of the CUD group was 43.56±31.13 months, while the OUD group was 68.00±33.20 months (p=0.005). The somatic (SOM) (p=0.011) and paranoid (PAR) (p=0.005) subscales of SCL-90-R were significantly different in the CUD and OUD groups. There was a significant difference between CUD and OUD groups in terms of IP (p=0.002) and PA (p=0.002) sub scores and total scores (p = 0.001) of CDS. Our study reveals that cannabis use is associated with more cognitive errors than opioid use. Higher scores of SOM and PAR in the OUD group than in the CUD group were thought to be associated with longer substance use.

Key words: Opioid addiction, cannabis, substance use disorder, cognition






Full-text options


Share this Article



Online Article Submission
• ejmanager.com
• ojshosting.net




eJManager.com
Review(er)s Central
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.